ATE474570T1 - Pharmazeutische zubereitung zur verwendung in der therapie oder prophylaxe von neoplastischen erkrankungen - Google Patents

Pharmazeutische zubereitung zur verwendung in der therapie oder prophylaxe von neoplastischen erkrankungen

Info

Publication number
ATE474570T1
ATE474570T1 AT06700207T AT06700207T ATE474570T1 AT E474570 T1 ATE474570 T1 AT E474570T1 AT 06700207 T AT06700207 T AT 06700207T AT 06700207 T AT06700207 T AT 06700207T AT E474570 T1 ATE474570 T1 AT E474570T1
Authority
AT
Austria
Prior art keywords
prophylaxis
therapy
glutamine
pharmaceutical preparation
alpha
Prior art date
Application number
AT06700207T
Other languages
German (de)
English (en)
Inventor
Stephan Pyerzynowski
Martyna Kandefer-Szerszen
Wojciech Rzeski
Original Assignee
Sgp & Sons Ab
Pierzynowski Stefan G
Martyna Kandefer-Szerszen
Wojciech Rzeski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sgp & Sons Ab, Pierzynowski Stefan G, Martyna Kandefer-Szerszen, Wojciech Rzeski filed Critical Sgp & Sons Ab
Application granted granted Critical
Publication of ATE474570T1 publication Critical patent/ATE474570T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT06700207T 2005-01-11 2006-01-10 Pharmazeutische zubereitung zur verwendung in der therapie oder prophylaxe von neoplastischen erkrankungen ATE474570T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL372183A PL372183A1 (pl) 2005-01-11 2005-01-11 Preparat przeciwnowotworowy oraz zastosowanie preparatu przeciwnowotworowego
PCT/PL2006/000003 WO2006075924A1 (en) 2005-01-11 2006-01-10 Antineoplastic preparation and the use of antineoplastic preparation

Publications (1)

Publication Number Publication Date
ATE474570T1 true ATE474570T1 (de) 2010-08-15

Family

ID=36168380

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06700207T ATE474570T1 (de) 2005-01-11 2006-01-10 Pharmazeutische zubereitung zur verwendung in der therapie oder prophylaxe von neoplastischen erkrankungen

Country Status (12)

Country Link
US (1) US7759396B2 (es)
EP (1) EP1845966B1 (es)
JP (2) JP2008526838A (es)
CN (1) CN101111241B (es)
AT (1) ATE474570T1 (es)
AU (1) AU2006205279B2 (es)
CA (1) CA2593780C (es)
DE (1) DE602006015608D1 (es)
DK (1) DK1845966T3 (es)
ES (1) ES2349233T3 (es)
PL (2) PL372183A1 (es)
WO (1) WO2006075924A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2033623A1 (en) 2007-09-07 2009-03-11 Cutech S.R.L. Compositions comprising ornithine ketoglutarate (OKG)
KR20160111529A (ko) * 2014-02-12 2016-09-26 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 노화 및 연령 관련 질환 및 증상의 치료를 위한 조성물 및 방법
WO2025263592A1 (ja) * 2024-06-19 2025-12-26 Ａｇｃ株式会社 グルタミン代謝阻害剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
FR2775901B1 (fr) * 1998-03-13 2000-07-21 Logeais Labor Jacques Sels de cetoacides et de derives amines, et leur utilisation pour la preparation de medicaments
SE0201713D0 (sv) * 2001-11-23 2002-06-06 Gramineer Internat Ab New methods and use III
CA2493764C (en) 2002-08-01 2011-05-24 Aesgen, Inc. Improved treatment of cancer with glutamine
AT412447B (de) * 2002-11-27 2005-03-25 C Y L Handelsges M B H Mittel mit zerstörender wirkung auf maligne tumore sowie verfahren zu seiner herstellung
ES2275218T3 (es) * 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
US20050124684A1 (en) * 2003-08-29 2005-06-09 Ying Du 5-(hydroxymethyl) furfural and derivatives as inhibitors of TNFalpha and IL-1beta production
DK1824470T3 (da) * 2004-12-17 2014-08-18 Cash Alan Brian Fremgangsmåde til forlængelse af levetiden og forsinke starttidspunktet for alders-relateret sygdom

Also Published As

Publication number Publication date
CA2593780A1 (en) 2006-07-20
DK1845966T3 (da) 2010-11-08
US20080058422A1 (en) 2008-03-06
JP2008526838A (ja) 2008-07-24
CN101111241B (zh) 2010-12-01
DE602006015608D1 (de) 2010-09-02
US7759396B2 (en) 2010-07-20
PL372183A1 (pl) 2006-07-24
ES2349233T3 (es) 2010-12-29
AU2006205279A1 (en) 2006-07-20
AU2006205279B2 (en) 2011-05-26
JP2013035864A (ja) 2013-02-21
EP1845966B1 (en) 2010-07-21
CA2593780C (en) 2013-11-26
WO2006075924A1 (en) 2006-07-20
PL1845966T3 (pl) 2011-02-28
CN101111241A (zh) 2008-01-23
EP1845966A1 (en) 2007-10-24

Similar Documents

Publication Publication Date Title
TNSN07452A1 (en) Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
AU2008267058A8 (en) Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine
IL185428A0 (en) 2-[isoquinolin-3- carbonyl) amino] - propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
UY27720A1 (es) Aroilpiridinonas monocíclicas,
BRPI0606301A2 (pt) processo para fabricar uma mistura de sais de acetato de polipeptìdeos, processo para fabricar uma mistura de sais de polipeptìdeos de trifluoroacetila não protegidos, mistura de sais de acetato de polipeptìdeos, composição farmacêutica, processos para a preparação de uma composição farmacêutica, e, mistura de polipeptìdeos de trifluoroacetila protegidos
WO2011107653A3 (en) Use of levodopa, carbidopa and entacapone for treating parkinson's disease
ATE510537T1 (de) Pharmazeutische zusammensetzungen von entacapon, levodopa und carbidopa mit verbesserter bioverfügbarkeit
CO6290629A2 (es) Composiciones de limpieza de amino ácido básico y métodos
ATE366106T1 (de) Zusammensetzung für die pharmazeutische oder dietätische verwendung zur bekämpfung von haarausfall
EA201100063A1 (ru) СПОСОБ ПОЛУЧЕНИЯ ПИРИДО-ПИРИМИДИНОВЫХ ИНГИБИТОРОВ mTOR КИНАЗЫ, ИХ СОЛЕВЫХ ФОРМ И ИХ ЛЕКАРСТВЕННЫХ ПРЕПАРАТОВ
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
ATE486620T1 (de) Biomimetisches verfahren zur beschichtung von substraten
WO2006062424A3 (en) Use of 3-hydroxy-3-methylbutyrate alone or in combination with alpha-ketoglutarate in the growth and mineralisation of the osteo-skeletal system
ATE474570T1 (de) Pharmazeutische zubereitung zur verwendung in der therapie oder prophylaxe von neoplastischen erkrankungen
TNSN07228A1 (en) Manufacture process of organic compounds
WO2021239928A3 (en) Treatment of cardiometabolic disease with inhibitors of type i interferon signalling
TW200612922A (en) Inhibitors of hsp90
UA94042C2 (ru) Применение агомелатина в получении лекарственных средств, предназначенных для лечения синдрома смита-магениса
MXPA05006408A (es) Derivados deuterizados de catecolamina y medicamentos comprendiendo estos compuestos.
ATE516040T1 (de) Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis
UA83900C2 (en) Amorphous forms of risedronate monosodium
PT1284945E (pt) Fertilizante contendo azoto para o crescimento de plantas
MX2022001076A (es) Metodo para tratar la enfermedad de alzheimer mediante la inhibicion de la captacion de aminoacidos por las celulas t.
BR0312712A (pt) Aminoácido modificado para a inibição da agregação plaquetária

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties